Amgen Ltd
- B02 - Antihemorrágicos
- NPLATE powder and solvent for solution for injection 250 µg+0.5 ml
- NPLATE powder and solvent for solution for injection 500 µg+1 ml
- NPLATE powder for solution for injection 125 µg
- NPLATE powder for solution for injection 250 µg
- NPLATE powder for solution for injection 500 µg
- B03 - Preparados antianémicos
- ARANESP PEN solution for injection 10 µg/0.4 ml
- ARANESP PEN solution for injection 100 µg/0.5 ml
- ARANESP PEN solution for injection 130 µg/0.65 ml
- ARANESP PEN solution for injection 15 µg/0.375 ml
- ARANESP PEN solution for injection 150 µg/0.3 ml
- ARANESP PEN solution for injection 20 µg/0.5 ml
- ARANESP PEN solution for injection 30 µg/0.3 ml
- ARANESP PEN solution for injection 300 µg/0.6 ml
- ARANESP PEN solution for injection 40 µg/0.4 ml
- ARANESP PEN solution for injection 50 µg/0.5 ml
- ARANESP PEN solution for injection 500 µg/1 ml
- ARANESP PEN solution for injection 60 µg/0.3 ml
- ARANESP PEN solution for injection 80 µg/0.4 ml
- ARANESP solution for injection 10 µg/0.4 ml
- ARANESP solution for injection 100 µg/0.5 ml
- ARANESP solution for injection 130 µg/0.65 ml
- ARANESP solution for injection 15 µg/0.375 ml
- ARANESP solution for injection 150 µg/0.3 ml
- ARANESP solution for injection 20 µg/0.5 ml
- ARANESP solution for injection 30 µg/0.3 ml
- ARANESP solution for injection 300 µg/0.6 ml
- ARANESP solution for injection 40 µg/0.4 ml
- ARANESP solution for injection 50 µg/0.5 ml
- ARANESP solution for injection 500 µg/1 ml
- ARANESP solution for injection 60 µg/0.3 ml
- ARANESP solution for injection 80 µg/0.4 ml
- C10 - Agentes modificadores de los lípidos
- REPATHA CARTRIDGE solution for injection 420 mg
- REPATHA PREFILLED PEN solution for injection 140 mg
- REPATHA PREFILLED SYRINGE solution for injection 140 mg
- H05 - Homeostasis del calcio
- MIMPARA film-coated tablet 30 mg
- MIMPARA film-coated tablet 60 mg
- MIMPARA film-coated tablet 90 mg
- MIMPARA gastro-resistant capsule, hard 1 mg
- MIMPARA gastro-resistant capsule, hard 2.5 mg
- MIMPARA gastro-resistant capsule, hard 5 mg
- PARSABIV solution for injection 10 mg/2 ml
- PARSABIV solution for injection 2.5 mg/0.5 ml
- PARSABIV solution for injection 5 mg/1 ml
- L01 - Antineoplásicos
- BLINCYTO powder for solution for infusion 38.5 µg
- IMLYGIC suspension for injection
- KANJINTI powder for solution for infusion 150 mg
- KANJINTI powder for solution for infusion 420 mg
- KYPROLIS powder for solution for injection 10 mg
- KYPROLIS powder for solution for injection 30 mg
- KYPROLIS powder for solution for injection 60 mg
- LUMYKRAS film-coated tablet 120 mg
- VECTIBIX concentrate for solution for infusion 100 mg/5 ml
- VECTIBIX concentrate for solution for infusion 200 mg/10 ml
- VECTIBIX concentrate for solution for infusion 400 mg/20 ml
- L03 - Inmunoestimulantes
- NEULASTA PREFILLED SYRINGE solution for injection 6 mg/0.6 ml
- NEULASTA PREFILLED SYRINGE WITH ON-BODY INJECTOR solution for injection 6 mg/0.6 ml
- NEUPOGEN SINGLEJECT solution for injection 300 µg(30 M IU)/0.5 ml
- NEUPOGEN SINGLEJECT solution for injection 480 µg(48 M IU)/0.5 ml
- NEUPOGEN solution for injection 300 µg(30 M IU)/1 ml
- L04 - Inmunosupresores
- AMGEVITA PREFILLED PEN solution for injection 40 mg/0.8 ml
- AMGEVITA PREFILLED SYRINGE solution for injection 20 mg/0.4 ml
- AMGEVITA PREFILLED SYRINGE solution for injection 40 mg/0.8 ml
- OTEZLA film-coated tablet 10 mg
- OTEZLA film-coated tablet 20 mg
- OTEZLA film-coated tablet 30 mg
- M05 - Preparados para el tratamiento de enfermedades óseas
- PROLIA PREFILLED SYRINGE solution for injection 60 mg/1 ml
- XGEVA solution for injection 120 mg/1.7 ml